GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet Neurol, 2019, 18(1): 56-87.
[2]
Jiang J Y, Gao G Y, Feng J F, et al. Traumatic brain injury in China [J]. Lancet Neurol, 2019, 18(3): 286-295.
[3]
Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury [J]. J Neurotrauma, 2007, 24 (Suppl 1): S1-106.
[4]
Shigemori M, Abe T, Aruga T, et al. Guidelines for the management of severe head injury, 2nd Edition guidelines from the guidelines committee on the management of severe head injury, the Japan society of neurotraumatology [J]. Neurol Med Chir (Tokyo), 2012, 52(1): 1-30.
[5]
Barbosa R R, Jawa R, Watters J M, et al. Evaluation and management of mild traumatic brain injury: an eastern association for the surgery of trauma practice management guideline [J]. J Trauma Acute Care Surg, 2012, 73(5 Suppl 4): S307-314.
[6]
Carney N, Totten A M, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, Fourth Edition [J]. Neurosurgery, 2017, 80(1): 6-15.
[7]
Lumba-Brown A, Yeates K O, Sarmiento K, et al. Centers for Disease Control and prevention guideline on the diagnosis and management of mild traumatic brain injury among children [J]. JAMA Pediatr, 2018, 172(11): e182853.
Bruenig D, Mehta D, Morris C P, et al. Fluid biomarkers for mild traumatic brain injury and related conditions [J]. Nat Rev Neurol, 2016, 12(10): 563-574.
[15]
Devic I, Hwang H, Edgar J S, et al. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease [J]. Brain, 2011, 134(Pt 7): e178.
[16]
Rodríguez-Rodríguez A, Egea-Guerrero J J, Gordillo-Escobar E, et al. S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury [J]. Neurol Res, 2016, 38(2): 130-137.
[17]
Czeiter E, Mondello S, Kovacs N, et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator [J]. J Neurotrauma, 2012, 29(9): 1770-1778.
[18]
Yan E B, Satgunaseelan L, Paul E, et al. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury [J]. J Neurotrauma, 2014, 31(7): 618-629.
[19]
Bogoslovsky T, Wilson D, Chen Y, et al. Increases of plasma levels of glial fibrillary acidic protein, Tau, and amyloid β up to 90 days after traumatic brain injury [J]. J Neurotrauma, 2017, 34(1): 66-73.
[20]
Dendrou C A, McVean G, Fugger L, et al. Neuroinflammation - using big data to inform clinical practice [J]. Nat Rev Neurol, 2016, 12(12): 685-698.
[21]
Kearney C J, Martin S J. An Inflammatory Perspective on Necroptosis [J]. Mol Cell, 2017, 65(6): 965-973.
[22]
Wang Y Q, Wang L, Zhang M Y, et al. Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model [J]. Neurochem Res, 2012, 37(9): 1849-1858.
[23]
Hosp F, Mann M. A primer on concepts and applications of proteomics in neuroscience [J]. Neuron, 2017, 96(3): 558-571.
2019, Vol. 30 
